MetLife Investment Management, LLC
Position in RCUS — Arcus Biosciences, Inc.
CIK 1529735
Whippany, NJ
Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$967,874
-$67,158 QoQ
Shares Held
44,809
+3.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. RCUS ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $967,874 | 44,809 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,035,032 | 43,434 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $563,883 | 41,462 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $337,500 | 41,462 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $259,136 | 33,011 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $499,187 | 33,525 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $474,051 | 31,004 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $472,190 | 31,004 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $531,169 | 28,134 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $537,359 | 28,134 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $505,005 | 28,134 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $571,401 | 28,134 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $491,221 | 26,931 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $556,933 | 26,931 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $691,958 | 26,451 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $670,268 | 26,451 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $790,230 | 25,039 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $643,958 | 15,912 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $554,851 | 15,912 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $505,209 | 18,398 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $516,615 | 18,398 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $477,612 | 18,398 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $315,341 | 18,398 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $387,057 | 15,645 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $217,152 | 15,645 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||